Filing Details

Accession Number:
0001562180-22-005938
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-08 16:04:19
Reporting Period:
2022-08-04
Accepted Time:
2022-08-08 16:04:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1590877 Regenxbio Inc. RGNX Biological Products, (No Disgnostic Substances) (2836) 471851754
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1652827 Vittal Vasista C/O Regenxbio Inc.
9804 Medical Center Drive
Rockville MD 20850
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-08-04 400 $35.00 154,840 No 4 S Direct
Common Stock Disposition 2022-08-05 17,280 $35.19 137,560 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. This transaction was effected pursuant to a Rule 10b5-1 trading plan.
  2. This transaction was executed in multiple trades at prices ranging from $35.00 to $35.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.